Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Jun 15;55(10):2056. doi: 10.1038/s41409-020-0962-x

Correction: Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma

Luxin Yang 1, Yamin Tan 1, Jimin Shi 1, Yanmin Zhao 1, Yuanyuan Zhu 1, Yongxian Hu 1, Wenjue Pan 1, Yishan Ye 1, Jingsong He 1, Weiyan Zheng 1, Jie Sun 1, Zhen Cai 1, He Huang 1, Yi Luo 1,✉
PMCID: PMC7608096  PMID: 32541688

Correction to: Bone Marrow Transplantation

10.1038/s41409-018-0184-7

The original version of this Article contained a mistake in Fig. 1 of non-relapse mortality (d). The solid line should represent the Allo-HSCT group and the dotted line should represent the Chemotherapy group. The description of the NRM of both groups in the figure’s legend is correct. Below is the updated figure.

graphic file with name 41409_2020_962_Fig1_HTML.jpg

Open in a new tab

Fig. 1

This has also been corrected in both the PDF and HTML versions of the Article.

Footnotes

The original article can be found online at 10.1038/s41409-018-0184-7.

Articles from Bone Marrow Transplantation are provided here courtesy of Nature Publishing Group

RESOURCES